로딩 중…
지수 로딩 중…
ROKIT Healthcare Inc.
376900· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩41,700-7.95%
2026-06-19
Price Chart
ROKIT Healthcare Inc.+198.07%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 661.94B KRW |
| Revenue | 30.61B KRW |
| Net Income | -4.33B KRW |
| Total Assets | 116.95B KRW |
| Net Assets | 11.29B KRW |
| Employees | 86 |
| Value | |
| P/B | 58.65x |
| P/S | 21.62x |
| FCF Yield | -2.63% |
| Profitability | |
| ROE | -38.35% |
| ROA | -3.70% |
| Op. Margin | -5.39% |
| Revenue Growth | 118.08% |
| Financial Health | |
| Debt Ratio | 1036.15% |
| Total Debt | 25.58B KRW |
| FCF | -17.39B KRW |
| Cash | 68.20B KRW |
| Current Ratio | 1.01x |
| Performance | |
| 1Y Return | 198.07% |
| 1M Return | -30.96% |
| From 52W High | -72.89% |
| 1Y MDD | -71.81% |
| Trading | |
| Volume | 321,976 shares |
| Foreign Own. | 1.16% |
| Per Share | |
| EPS | -282 KRW |
| BPS | 683 KRW |
Company Info
Rokit Healthcare, established in 2012, leads the innovative regenerative medicine market. The company has commercialized AI ultra-precision patient-specific organ and skin regeneration platforms, built upon four core technologies including AI for medical lesion modeling and disposable regeneration kits. It provides an economical treatment method for chronic diseases, achieving 90% regeneration with a single procedure, and is expanding its application to cartilage and kidney regeneration platforms. Rokit Healthcare is headquartered in Geumcheon-gu, Seoul Metropolitan City.